8-K: Body and Mind Inc. Subsidiary to Sell Nevada Medical Group for $2 Million

Body and Mind Inc.'s subsidiary, DEP Nevada, Inc., has agreed to sell its membership interest in Nevada Medical Group, LLC for a total of $2 million, including cash, a promissory note, and potential working capital adjustments.

Summary

• Body and Mind Inc.'s wholly-owned subsidiary, DEP Nevada, Inc., has entered into an agreement to sell its membership interest in Nevada Medical Group, LLC to Vegas Brazil LLC for $2 million.
• The purchase price includes a $250,000 cash deposit already paid, $750,000 in cash to be paid within six months of regulatory approval, and a $1,000,000 secured promissory note.
• The promissory note will bear interest at the applicable federal rate and will be paid in six equal monthly installments starting seven months after the closing date.
• The purchase price is subject to a working capital adjustment based on the difference between the actual working capital and a target of $0.00.
• A side letter agreement allows the purchaser to assume operational costs and long-term leases during the transition period, which began on December 15, 2023.
• The purchaser will also have a limited, royalty-free license to use the seller's trademarks for the first six months, followed by a $5,000 monthly fee for the next six months, with potential month-to-month renewal at the same rate.
• The closing of the transaction is contingent upon regulatory approval from the Nevada Cannabis Compliance Board and other conditions.

Sentiment

Score: 7

Explanation: The document outlines a strategic sale of a subsidiary, which is generally positive for the seller. The deal structure includes a mix of cash and a promissory note, which is a common practice. The sentiment is moderately positive, reflecting a planned transaction with some inherent risks.

Positives

• The sale provides Body and Mind Inc. with an immediate cash deposit of $250,000.
• The deal includes a further $750,000 cash payment upon regulatory approval, providing additional capital.
• The secured promissory note of $1,000,000 provides a future income stream.
• The buyer assumes operational costs and long-term leases during the transition period, reducing the seller's financial burden.
• The limited trademark license provides a potential revenue stream for the seller after the initial royalty-free period.

Negatives

• The full $2 million purchase price is not received upfront, with $750,000 contingent on regulatory approval and $1,000,000 paid over time via a promissory note.
• The purchase price is subject to a working capital adjustment, which could reduce the final amount received.
• The seller is granting a royalty-free license for the first six months, foregoing potential revenue.
• The transaction is dependent on regulatory approval, which introduces uncertainty and potential delays.
• The seller is exposed to the risk of the buyer not fulfilling the terms of the promissory note.

Risks

• The transaction is contingent on receiving regulatory approval from the Nevada Cannabis Compliance Board, which could be delayed or denied.
• The working capital adjustment could result in a lower final purchase price than anticipated.
• The buyer may not be able to make the payments on the promissory note, leading to potential losses for the seller.
• There is a risk that the buyer may not be able to successfully operate the business, which could impact the value of the promissory note.
• The buyer's assumption of operational costs and leases during the transition period could lead to unforeseen liabilities for the seller if not managed properly.

Future Outlook

The transaction is expected to close within fifteen calendar days following receipt of regulatory approval and satisfaction of other conditions. The buyer will assume operational control and costs during the transition period. The parties will negotiate a long-term trademark license agreement within the first six months of the license term.

Industry Context

This transaction reflects the ongoing consolidation and M&A activity within the cannabis industry, as companies seek to optimize their operations and market presence. The sale of Nevada Medical Group allows Body and Mind Inc. to divest a non-core asset and potentially focus on other strategic priorities. The buyer, Vegas Brazil LLC, is expanding its footprint in the cannabis market.

Comparison to Industry Standards

• The structure of the deal, including a mix of cash, a promissory note, and a working capital adjustment, is common in the cannabis industry.
• The use of personal guarantees from an affiliate of the purchaser is a measure to mitigate risk for the seller.
• The side letter agreement allowing the buyer to assume operational control during the transition period is a common practice to ensure a smooth handover.
• The trademark licensing agreement is a way for the seller to retain some value from its brand while divesting the business.
• Comparable transactions in the cannabis industry often involve similar deal structures and contingencies, reflecting the regulatory and operational complexities of the sector.

Stakeholder Impact

• Shareholders of Body and Mind Inc. will see a divestment of a subsidiary and a potential influx of cash.
• Employees of Nevada Medical Group, LLC will transition to new ownership under Vegas Brazil LLC.
• Customers of Nevada Medical Group, LLC may experience changes in operations and branding.
• Suppliers and creditors of Nevada Medical Group, LLC will be impacted by the change in ownership.

Next Steps

• The seller will submit the Transfer of Interest application to the Nevada Cannabis Compliance Board.
• The buyer will obtain regulatory approval for the change in ownership.
• The parties will execute the First and Second Guarantees.
• The buyer will deliver the promissory note on the closing date.
• The parties will determine the working capital adjustment based on the statement of financial position.
• The parties will negotiate a long-form trademark license agreement within the first six months of the license term.

Key Dates

Keywords

cannabis, acquisition, sale, membership interest, Nevada Medical Group, Body and Mind Inc., Vegas Brazil LLC, regulatory approval, promissory note, working capital, trademark license